Mustafa S Siddiqui
Overview
Explore the profile of Mustafa S Siddiqui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
663
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Siddiqui M, Mari Z
Parkinsonism Relat Disord
. 2024 Apr;
125:106956.
PMID: 38616453
No abstract available.
2.
Liebenow B, Jiang A, DiMarco E, Sands L, Moya-Mendez M, Laxton A, et al.
Sci Rep
. 2024 Mar;
14(1):4627.
PMID: 38438386
Impulse Control Disorder (ICD) in Parkinson's disease is a behavioral addiction induced by dopaminergic therapies, but otherwise unclear etiology. The current study investigates the interaction of reward processing variables, dopaminergic...
3.
Liebenow B, Wilson T, Maas B, Aladnani E, Moran R, White J, et al.
bioRxiv
. 2023 Sep;
PMID: 37745618
Background: Impulse Control Disorder (ICD) in Parkinson's disease is a behavioral addiction arising secondary to dopaminergic therapies, most often dopamine receptor agonists. Prior research implicates changes in striatal function and...
4.
DiMarco E, Sadibolova R, Jiang A, Liebenow B, Jones R, Haq I, et al.
Parkinsonism Relat Disord
. 2023 Aug;
114:105800.
PMID: 37595329
Decreasing dopaminergic function is at the core of Parkinson's disease (PD) motor symptoms and changes in dopaminergic action are associated with many comorbid non-motor symptoms in PD. Notably, dopaminergic signaling...
5.
Chaudhuri K, Kovacs N, Pontieri F, Aldred J, Bourgeois P, Davis T, et al.
J Parkinsons Dis
. 2023 Jun;
13(5):769-783.
PMID: 37302039
Background: Levodopa-carbidopa intestinal gel (LCIG) improves motor and non-motor symptoms in patients with advanced Parkinson's disease (aPD). Objective: To present the final 36-month efficacy and safety results from DUOGLOBE (DUOdopa/Duopa...
6.
Ruckart K, Wilson C, Moya-Mendez M, Madden L, Laxton A, Siddiqui M
Tremor Other Hyperkinet Mov (N Y)
. 2023 May;
13:13.
PMID: 37152623
Background: There is a paucity of literature examining the effect of Ventral Intermediate Nucleus (VIM) deep brain stimulation (DBS) on voice in patients with vocal tremor (VT). Objective: Investigate the...
7.
Duffley G, Szabo A, Lutz B, Mahoney-Rafferty E, Hess C, Ramirez-Zamora A, et al.
Parkinsonism Relat Disord
. 2023 Mar;
109:105346.
PMID: 36966051
Introduction: Deep brain stimulation (DBS) is an effective treatment for Parkinson's disease (PD), but its efficacy is tied to DBS programming, which is often time consuming and burdensome for patients,...
8.
DiMarco E, Sadibolova R, Jiang A, Liebenow B, Jones R, Ul Haq I, et al.
bioRxiv
. 2023 Mar;
PMID: 36909605
One Sentence Summary: Quantitative characterization of time perception behavior reflects individual differences in Parkinson's disease motor and non-motor symptom clinical presentation that are consistent with hypothesized neural and cognitive mechanisms.
9.
Liebenow B, Jiang A, DiMarco E, Wilson T, Siddiqui M, Ul Haq I, et al.
Neurosurg Focus
. 2023 Feb;
54(2):E3.
PMID: 36724520
Objective: To the authors' knowledge, no data have been reported on dopamine fluctuations on subsecond timescales in humans with alcohol use disorder (AUD). In this study, dopamine release was monitored...
10.
Soileau M, Pagan F, Fasano A, Rodriguez-Cruz R, Yan C, Gupta N, et al.
Neurol Ther
. 2023 Jan;
12(2):459-478.
PMID: 36652111
Introduction: Complex polypharmacy regimens to manage persistent motor fluctuations result in significant pill burden for patients with advanced Parkinson's disease (APD). This study evaluated the effectiveness of carbidopa/levodopa enteral suspension...